Synergistic effects of interleukin-11 with other growth factors on the expansion of hematopoietic progenitors from normal individuals and chronic myeloid leukemia patients resistant to treatment with cytosine arabinoside or Eilatin

Leukemia Research

Volumn 20, Issue 9, 1996, Pages 751-759

  Einat, Michal ^a   Nagler, Arnon ^b   Amiel, Aliza ^c   Fejgin, Moshe D ^c   Rudi, Amira ^a   Kashman, Yoel ^a   Fabian, Ina ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

Author keywords

CML; IL 11; Myeloid progenitors

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; EILATIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 11; INTERLEUKIN 3; PROTEIN BCL 2; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE MARROW CELL; CASE REPORT; CELL CULTURE; CELL GROWTH; CHRONIC MYELOID LEUKEMIA; COLONY FORMING UNIT C; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

EID: 0030250342     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(96)00039-2     Document Type: Article

References (36)

1. - cells and synergizes with stem cell factor interleukin-3, and granulocyte-macrophage colony-stimulating factor. Exp. Hematol. 21, 1668.
2. 2. Tsuji K., Lyman S. D., Sudo T., Clark S. C. & Ogawa M. (1992) Enhancement of murine hematopoiesis by synergystic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood 11, 2855.
3. 3. Brandt J. E. & Hoffman R. (1993) Interleukin-11 plays a pivotal role in the in vitro expansion of human hematopoietic progenitor and stem cells. (abstr. suppl I). Blood 82, 368a.
4. 4. Keller D. C., Du X. X., Srour E. F., Hoffman R. & Williams D. A. (1993) Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in long term marrow cultures. Blood 82, 1428.
5. 5. Schibler K. R., Yang Y. C. & Christensen R. D. (1992) Effect of interleukin-11 on cycling status and clonogenic maturation of fetal and adult hematopoietic protenitors. Blood 80, 900.
6. 6. Musashi M., Clark S. C., Sudo T., Urdal D. L. & Ogawa M. (1991) Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice. Blood 78, 1448.
7. 7. Stone R. M., Spriggs D. R., Dhawan R. K., Arthur K. A., Mayer R. J. & Kufe D. W. (1990) A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemia. Leukemia 4, 843.
8. 8. Herzig R. H., Wolff S. N., Lazarus H. M., Phillips G. L., Karanes L. C. & Herzig G. P. (1983) High dose cytosine arabinoside therapy for refractory leukemia. Blood 62, 361.
9. 9. Capizzi R. L., Poole M., Cooper R. M. & Smith J. (1984) Treatment of poor risk acute leukemia with sequential high dose ARA-C and asparaginase. Blood 63, 694.
10. 10. Major P. P., Egan E. M., Beardsley G. P., Minden M. D. & Kufe D. W. (1981) Lethality of human myefoblasts correlates with the incorporation of ARA-C in DNA. Proc. Natl Acad. Sci. USA 78, 3235.
11. 11. Kufe D., Spriggs D., Egan E. M. & Monroe D. (1984) Relationships among ARA-CTP pools, formation of (ARA-C) DNA, and cytotoxicity of human leukemic cells. Blood 64, 54.
12. 12. Hiddemann W., Schleyer E., Unterhalt M., Zulsodrf M., Rolf C., Reuter C., Kewer U., Uhrmeister C., Wormann B. & Buchner T. (1992) Differences in the intracellular pharmacokinetics of cytosine arabinoside (ARA-C) between circulating leukemic blasts and normal mononuclear blood cells. Leukemia 6, 1273.
13. 13. Han J. H., Gileadi C., Rajapaksa R., Kosek J. & Greenberg P. L. (1995) Modulation of apoptosis in human myeloid leukemic cells by GM-CSF. Exp. Hematol. 23, 265.
14. 14. Shochet N. R., Rudi A., Kashman Y., Hod Y., El-Maghrabi M. R. & Spector I. (1993) Novel marine alkaloids from the tunicate Eudistoma sp. are potent regulators of cellular growth and differentiation and affect cAMP-mediated processes. J. Cell. Physiol. 157, 481.
15. 15. Einat M., Lishner M., Amiel A., Nagler A., Yarkoni S., Rudi A., Kashman Y., Markel D. & Fabian I. (1995) Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells of chronic myeloid leukemia patients. Exp. Hematol. 23, 1442.
16. 16. Lishner M., Shur I., Bleiberg I., Rudi A., Kashman Y. & Fabian I. (1995) Sensitivity of hematopoietic progenitors of acute myeloblastic leukemia to new compounds derived from marine organisms. Leukemia 9, 1543.
17. 17. Rudi A., Benayahu Y., Goldberg I. & Kashman Y. (1988) Eilatin: A novel alkaloid from the tunicate Eudistoma sp. Tetrahedron. Lett. 29, 6655.
18. 18. Paul S. R., Bennett F., Calvetti J. A., Kelleher K., Wood C. R., O'Hara R. M. Jr., Leary A. C., Sibley B., Clark S. C., Williams D. A. & Yang Y. C. (1990) Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl. Acad. Sci. USA 87, 7512.
19. 19. Bruno E., Briddell R. A., Cooper R. J. & Hoffman R. (1991) Effects of recombinant interleukin-11 on human megakarocyte progenitor cells. Exp. Hematol. 19, 378.
20. 20. Nash R. A., Seidel K., Storb R., Slichter S., Schuening F. G., Appelbaum F. R., Becker A. B., Bolles L., Deeg H. J., Graham T., Hackman R. C. & Burstein S. A. (1995) Effect of rhIL-11 on normal dogs and after sublethal radiation. Exp. Hematol. 23, 389.
21. 21. Du X. X., Keller D., Maze R. & Williams D. A. (1993) Comparative effects of in vivo treatment using interleukin-11 and stem cell factor on reconstitution in mice after bone marrow transplantation. Blood 82, 1016.
22. - cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood 77, 2316.
23. 23. Moore M. & Warren D. J. (1987) Synergy of interleukin-1 and granulocyte colony-stimulating factor: In vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proc. Natl. Acad. Sci. USA 84, 7134.
24. 24. Moreb J., Zucali J. R. & Weiner R. S. (1989) The role of interleukin 3 and interleukin 6 in the protection from 4-hydroperoxyclophosphamide and the proliferation of early human hematopoietic progenitor cells. Exp. Hematol. 17, 1022.
25. 25. Tepler I., Elias A., Kalish L., Shulman L., Strauss G., Skarin A., Lynch T., Levitt D., Resta D., Demetri G., Gaynes L. & Schnipper L. (1994) Effect of recombinant human interleukin-3 on haematological recovery from chemotherapy-induced myelosuppression. Brit. J. Haematol. 87, 678.
26. 26. Mumcuoglu M., Naparstek E. & Slavin S. (1990) The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow. Bone Marrow Transplant. 5, 153.
27. 27. Du X. X., Neben T., Goldman S. & Williams D. A. (1993) Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: acceleration of recovery of peripheral blood neutrophils and platelets. Blood 81, 27.
28. 28. Leonard J. P., Quinto C. M., Kozitza M. K., Neben T. Y. & Goldman S. J. (1994) Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood 83, 1499.
29. 29. Hu J. P., Cesano A., Santoli D., Clark S. C. & Hoang T. (1993) Effects of interleukin-11 on the proliferation and cell cycle status of myeloid leukemic cells. Blood 81, 1586.
30. 30. Spiro T. E., Mattelaer M. A., Efira A. & Stryckmans P. (1981) Sensitivity of myeloid progenitor cells in healthy subjects and patients with chronic myeloid leukemia to chemotherapeutic agents. J. Natl. Cancer Inst. 66, 1053.
31. 31. Robertson M. J., Trantravahi R., Griffin J. D., Canellos G. P. & Cannistra S. A. (1993) Hematologic remission and cytogenetic improvement after treatment of stable-phase chronic myelogenous leukemia with continuous infusion of low-dose cytarabine. Am. J. Hematol. 43, 95.
32. 32. Coulombel L., Kalousek D. K., Eaves C. J., Gupta C. M. & Eaves A. C. (1983) Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. N. Engl. J. Med. 308, 1493.
33. 33. Chang J., Morgenstern G., Deakin D., Testa N. G., Courtinho I., Scarffe J. H., Harrison C. & Dexter T. M. (1988) Reconstitution of haemopoietic system with autologous marrow taken during relapse of acute myeloblastic leukaemia and grown in long-term culture. Lancet 1, 294.
34. 34. Carell A. M., Gaozza E., Raffo M. R., Carlier P., Frassoni F., Valbonesi M., Lercari G., Sessarego M., Deffarari R., Guerrasio A., Saglio G., Carepa L., Gaetani G. F. & Occhini D. (1991) Therapy of acute phase CML with intensive chemotherapy, blood cell autograft and cyclosporine A. Leukemia 5, 517.
35. 35. Daley G. Q. & Goldman J. M. (1993) Autologous transplant for CML revisited. Exp. Hematol. 21, 734.
36. 36. Reiffers J., Trouette R., Marit G., Mortastrue M., Faberes C., Cony-Makhoul P., David B., Bourdeau M. J., Bikou-Nabera C., Lancombe F., Feuillatre-Fabre F., Vezon G., Bermard P. H. & Broustet A. (1991) Autologous blood stem cell transplantation for CML in transformation: a report of 47 cases. Br. J. Haematol. 77, 339.